Home » Topics » BioWorld Science, Hematologic

BioWorld Science, Hematologic
RSS

University of Bern, Silence Therapeutics describe nucleic acids inhibiting PROS1

Nov. 30, 2020

Evrenzo approved in Japan for CKD anemia in adults not on dialysis

Nov. 27, 2020

Late events dog gene therapy

Nov. 24, 2020

Functional analysis complements sequencing

Nov. 17, 2020

FDA complete response letter for sutimlimab cites third-party manufacturing issues

Nov. 16, 2020

Rallybio begins phase I/II study of RLYB-211 for fetal and neonatal alloimmune thrombocytopenia

Nov. 11, 2020

Medshine Discovery synthesizes new factor XIa inhibitors

Nov. 6, 2020

Adakveo approved in Europe to prevent VOCs in patients with sickle cell disease

Nov. 4, 2020

A novel inducer of fetal hemoglobin with improved PK and PD properties

Nov. 3, 2020

INSERM and collaborators describe hematopoietic stem cells including beta globin gene

Nov. 2, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
Ontrack Therapeutics divulges compounds for neurodegenerative diseases
BioWorld Science
Ontrack Therapeutics Ltd. has reported new heterotricyclic compounds potentially useful for the treatment of neurodegenerative diseases.
CINP 2026: organoids reveal autism and addiction mechanisms
BioWorld Science
At the 2026 World Congress of Neuropsychopharmacology (CINP), held in Glasgow June 26-29, 2026, researchers from Japan’s National Center of Neurology and...
Reunion Neuroscience reports new 5-HT2A partial agonists and/or 5-HT2B antagonists
BioWorld Science
Reunion Neuroscience Inc. has identified new 5-HT2A receptor partial agonists and/or 5-HT2B receptor antagonists potentially useful for the treatment of...